VU534 is a NAPE-PLD activator, with an EC50 of 0.30 µM. VU534 is dual inhibitors of FAAH and sEH (IC50 of 1.2 µM). VU534 increases efferocytosis in a NAPE-PLD dependent manner. VU534 has the potential for cardiometabolic diseases study [1] .
Molecular Weight:
447.55
Purity:
98.10
CAS Number:
[923509-20-0]
Formula:
C21H22FN3O3S2
Target:
Beta-lactamase,Epoxide Hydrolase,FAAH
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
